The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 20
- 3 new, 17 renewals
- Median first-year cost
- $178,784
- $3,523,999 in all
- Institutions
- 20
- 20 contact PIs
Awards by fiscal year
0
0
0
20
0
0
0
0
0
0
0
0
0
14151617181920212223242526
Fiscal years 2014 to 2026.
Most frequent institutions
- BAYLOR COLLEGE OF MEDICINE1
- BECKMAN RESEARCH INSTITUTE/CITY OF HOPE1
- CHILDREN'S HOSPITAL OF LOS ANGELES1
- DANA-FARBER CANCER INST1
- DUKE UNIVERSITY1
and 15 other institutions
Most frequent study sections
- Special Emphasis Panel (ZHL1 CSR-C (M1))20
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2017 | Novel Strategies for Assessing and Optimizing Therapy for Minimal Residual Disease after Allogeneic Transplantation for AML and MDS1UG1HL138658-01 | Maziarz, Richard Thomas | OREGON HEALTH & SCIENCE UNIVERSITY, OR | First-year cost $202,916 | Study section ZHL1 |
| FY2017 | Targeting HIV and EBV Antigens in Patients with HIV Lymphoma2UG1HL108945-07 | Bollard, Catherine M.Heslop, Helen E | BAYLOR COLLEGE OF MEDICINE, TX | First-year cost $198,339 | Study section ZHL1 |
| FY2017 | Blood & Marrow Clinical Trials Network- Hutchinson Center as Core Clinical Site2UG1HL069246-17 | Appelbaum, Frederick | FRED HUTCHINSON CANCER RESEARCH CENTER, WA | First-year cost $198,150 | Study section ZHL1 |
| FY2017 | Core Clinical Centers for the Blood and Marrow Transplant Clinical Trials Network (UG1)2UG1HL108987-07 | Pidala, Joseph A | H. LEE MOFFITT CANCER CTR & RES INST, FL | First-year cost $194,404 | Study section ZHL1 |
| FY2017 | The Ohio State University Blood and Marrow Transplant Research Consortium2UG1HL109322-07 | Vasu, Sumithira | OHIO STATE UNIVERSITY, OH | First-year cost $194,009 | Study section ZHL1 |
| FY2017 | MSKCC BMT CTN Renewal2UG1HL069315-17 | Perales, Miguel-Angel | SLOAN-KETTERING INST CAN RESEARCH, NY | First-year cost $193,800 | Study section ZHL1 |
| FY2017 | Mount Sinai Core Clinical Consortium for the BMT Clinical Trials Network1UG1HL138645-01 | Levine, John | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | First-year cost $193,233 | Study section ZHL1 |
| FY2017 | A randomized phase 2 trial to compare standard-of-care steroids vs. steroids plus low-dose IL-2 vs. steroids plus low-dose IL-2 and rituximab for upfront treatment of chronic GVHD2UG1HL069249-17 | Antin, Joseph H | DANA-FARBER CANCER INST, MA | First-year cost $193,072 | Study section ZHL1 |
| FY2017 | City of Hope Core Clinical Center for the Blood and Marrow Transplant Clinical Trials Network2UG1HL069278-17 | Nakamura, Ryotaro | BECKMAN RESEARCH INSTITUTE/CITY OF HOPE, CA | First-year cost $180,994 | Study section ZHL1 |
| FY2017 | Unrelated Donor BMT vs. Immune Suppression for Newly Diagnosed Severe Aplastic Anemia in Children and Young Adults: BMT CTN Core Center Renewal for the Pediatric Blood and Marrow Transplant Consortium2UG1HL069254-17 | Pulsipher, Michael A | CHILDREN'S HOSPITAL OF LOS ANGELES, CA | First-year cost $180,568 | Study section ZHL1 |
| FY2017 | Abramson Cancer Center BMT/CTN Core Clinical Center2UG1HL069286-17 | Stadtmauer, Edward A | UNIVERSITY OF PENNSYLVANIA, PA | First-year cost $177,000 | Study section ZHL1 |
| FY2017 | Core Clinical Centers for the Blood and Marrow Transplant Clinical Trials Network1UG1HL138641-01 | Hari, Parameswaran N | MEDICAL COLLEGE OF WISCONSIN, WI | First-year cost $175,562 | Study section ZHL1 |
| FY2017 | University of Michigan Core Clinical Center for the BMT Research Network2UG1HL069330-17 | Reddy, PavanYanik, Gregory A | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | First-year cost $170,133 | Study section ZHL1 |
| FY2017 | Blood and Marrow Transplant Clinical Trials Network2UG1HL069274-17 | Kurtzberg, Joanne | DUKE UNIVERSITY, NC | First-year cost $169,182 | Study section ZHL1 |
| FY2017 | Core Clinical Consortium for Blood and Marrow Transplant Clinical Trials Network2UG1HL069301-17 | Wingard, John R. | UNIVERSITY OF FLORIDA, FL | First-year cost $166,944 | Study section ZHL1 |
| FY2017 | ALT-803 (IL-15/IL-15Rα-Fc) maintenance after allogeneic transplantation for AML2UG1HL069290-17 | Brunstein, Claudio G. | UNIVERSITY OF MINNESOTA, MN | First-year cost $151,167 | Study section ZHL1 |
| FY2017 | Reduction of Relapse Risk Through Incorporation of Novel Biologic Agents Following Reduced Intensity Haploidentical Donor Transplant for Acute Myeloid Leukemia.2UG1HL109526-07 | Bashey, AsadCopelan, Edward A.Komanduri, Krishna V. | NORTHSIDE HOSPITAL ATLANTA, GA | First-year cost $150,674 | Study section ZHL1 |
| FY2017 | A Phase II Study of Cytokine Induced Memory-like (CIML) Natural Killer (NK) Cell Adoptive Therapy after Haploidentical Donor Hematopoietic Cell Transplantation.2UG1HL109137-07 | Westervelt, Peter | WASHINGTON UNIVERSITY, MO | First-year cost $148,895 | Study section ZHL1 |
| FY2017 | Translational Research in Blood and Marrow Transplantation2UG1HL069310-17 | Jones, Richard J | JOHNS HOPKINS UNIVERSITY, MD | First-year cost $143,641 | Study section ZHL1 |
| FY2017 | BMT Clinical Trial Network at Stanford2UG1HL069291-17 | Lowsky, Robert | STANFORD UNIVERSITY, CA | First-year cost $141,316 | Study section ZHL1 |
Newest fiscal year first, then first-year cost.
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-15-0.3.4. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.